<DOC>
<DOCNO>EP-0649656</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Pharmaceutical compositions based on acriflavine useful for the treatment of herpes and zona
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3147	A61K3147	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The present invention relates to the combined use of acriflavine and of an 8-hydroxyquinoline compound for the preparation of a pharmaceutical composition which is useful in the treatment of herpes and zona.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
RICHARD LAB M
</APPLICANT-NAME>
<APPLICANT-NAME>
LABORATOIRE M. RICHARD
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
FROISSANT-RICHARD SOLANGE
</INVENTOR-NAME>
<INVENTOR-NAME>
RICHARD MARCEL
</INVENTOR-NAME>
<INVENTOR-NAME>
FROISSANT-RICHARD, SOLANGE
</INVENTOR-NAME>
<INVENTOR-NAME>
RICHARD, MARCEL
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Combined use of acriflavine or of one of its pharmaceutically
acceptable salts, and an 8-hydroxyquinoline compound for the

manufacture of a pharmaceutical composition for the treatment of
herpes and zona.
Use according to claim 1, characterized in that the 8-hydroxyquinoline
compound is 8-hydroxyquinoline, 8-benzoyloxyquinoline

or 8-hydroxyquinoline sulfate.
Use according to claim 2, characterized in that the 8-hydroxyquinoline
compound is 8-hydroxyquinoline sulfate.
Use according to any one of claims 1 to 3, characterized in that
the weight ratio acriflavine/8-hydroxyquinoline compound is between

0.75 and 5.
Use according to claim 4, characterized in that the weight ratio
acriflavine/8-hydroxyquinoline compound is equal to 0.75.
Use according to claim 4, characterized in that the weight ratio
acriflavine/8-hydroxyquinoline compound is equal to 1.
Use according to claim 4, characterized in that the weight ratio
acriflavine/8-hydroxyquinoline compound is equal to 5.
Use of an 8-hydroxyquinoline compound selected from 8-hydroxyquinoline,
8-benzoyloxyquinoline and 8-hydroxyquinoline

sulfate as an agent potentiating the activity of acriflavine to inhibit
the multiplication of the herpes and zona viruses.
</CLAIMS>
</TEXT>
</DOC>
